Showing results (421-430 of 580) with videos related to
Sort By:
Pageof 58
Bone Marrow Transplantation|April 10, 1999
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled studyS M Kelsey, J M Goldman, S McCann, et al.Haematologica|June 28, 2000
Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilizationE Olavarria, S Parker, C Craddock, et al.Blood|August 8, 1998
The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biologyF Dazzi, D Capelli, R Hasserjian, et al.Cytotherapy|October 25, 2002
CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effectI A Dodi, F Van Rhee, H C Forde, et al.Leukemia|December 1, 1994
Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell linesS G O'Brien, M A Kirkland, J V Melo, et al.Toxicology|January 1, 1992
Effect of inhaled methanol on pituitary and testicular hormones in chamber acclimated and non-acclimated ratsR L Cooper, M L Mole, G L Rehnberg, et al.Histopathology|August 1, 1985
Selective sparing of enterochromaffin cells in graft versus host disease affecting the colonic mucosaI A Lampert, P Thorpe, S van Noorden, et al.Cancer Genetics and Cytogenetics|December 1, 1985
Atypical promyelocytic leukemia (M3) with immature primary granules and t(15;17)L Parreira, E Matutes, R E Marcus, et al.British Journal of Haematology|August 12, 1999
Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in childrenS B Marley, J L Lewis, R J Davidson, et al.Bone Marrow Transplantation|October 1, 1994
Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemiaF van Rhee, F Lin, N C Cross, et al.Pageof 58